Replies to post #1427 on Amyris Inc (fka AMRSQ)

[StockMonster100]

Big Afterhours buy today. 201,520 shares bought. mmmmmm, I wonder.....

[BottomBounce]

$AMRS & Biogen. $BIIB Collaboration $300+ #Biotech Stock Amyris recently announced partnership with Biogen, Inc. to develop alternative cell lines supporting production of therapeutics, marking second major partnership in biopharma market, which is now positioned to become Amyris’s largest opportunity for collaborations. The Biogen partenrship is the most exciting of all,” CEO John Melo said,. With it, Amyris he said would make “ a transformative change to biopharma where partner would be able to employ [Amyris biotechnology] instead of using cells from mammals. Others have attempted and failed, but we are positioned to deliver life saving therapeutics and make them more widely available. This could be game changing for biopharmaceuticals, and Biogen will fully fund the development.”
http://www.biofuelsdigest.com/bdigest/2016/08/14/amyris-the-new-colossus-aims-to-unlock-its-golden-door/

[BottomBounce]

$AMRS 46c Up 5% on a roll. Price Target $2.6 Company Says Strong 2H, Record Yearly Revenues, Positive Cash flow: http://www.marketwatch.com/story/amyris-ginkgo-bioworks-complete-collaboration-agreement-to-accelerate-commercialization-of-bio-based-products-2016-09-15